An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression

Journal:

Nature Communications

Published:

2026-01-21

DOI:

10.1038/s41467-026-68699-4

Affiliations:

10

Authors:

14

Go to article

Institutions	Authors	Share
Liaoning Normal University (LNNU), China	3.000000	0.21
University of Chinese Academy of Sciences (UCAS), China	2.833333	0.20
CAS Center for Excellence in Molecular Cell Science, SIBS CAS, China	2.583333	0.18
Shanghai Chest Hospital, SJTU, China	2.333333	0.17
The First Affiliated Hospital of Wenzhou Medical University, China	2.000000	0.14
Renji Hospital, SJTU, China	1.000000	0.07
Shanghai Academy of Natural Sciences (SANS), China	0.250000	0.02

Interested in Oncology and Carcinogenesis?